homoharringtonine , a chemotherapeutic drug used in the so-called hoap regimen for acute nonlymphocytic leukemia , seems to possess the capability of inducing hl-60 , the promyelocytic leukemia cell line , to nbt positive myeloid terminal cells , although the inducing effect is weaker than retinoic acid .
C0023467
acute nonlymphocytic leukemia
C0023487
promyelocytic leukemia